Press Releases
   Company Newsletter
   Media Coverage
   Special Events
   
     
 
   
 

Current Issues - Newsletter
April 1997

 
 
 

NEWS FLASH

 
 
   
  Spices Board of India Honors Dr. Majeed
 
 
 

The Indian government has again recognized Dr. Muhammed Majeed for his continuing efforts in new product development.


The Spices Board of India honored Dr. Majeed for pioneering the development and commercialization of Garcinia cambogia.

 
   
 

New Products : Bacopin™ (Bacopa monniera)

 
 
 
Often referred to as brahmi, Bacopa monniera was prized by Ayurvedic physicians as an effective brain tonic. Bacopin™ contains bacosides, the active principles responsible for improving memory related functions. These compounds are attributed with the capability of enhancing the efficiency of transmission of nerve impulses, thereby strengthening memory and cognition.

Bacopin™ is a trademark of Sabinsa Corporation. Please feel free to call for more information, or to speak directly with one of our scientific staff consultants about Bacopin or other quality Sabinsa products.

 
   
 

Glucosamine S04 Vs. HCl Which is the preferred form?

 
 
 
Glucosamine sulfate is the preferred form of glucosamine for therapeutic use, mainly as an antiarthritic agent. It is an effective means of providing glucosamine orally and as a building block for the regeneration of cartilage glycosaminoglycans lost during the progression of osteoarthritis.
  1. Glucosamine sulfate occurs naturally in the human body and is almost devoid of toxicity, making it suitable for long-term clinical use1.

  2. The chondrometabolic, antireactive and antiarthritis properties of this form have been investigated extensively and are supported by controlled clinical trials2.

  3. Pharmacokinetic studies revealed that close to 90% of orally administered glucosamine sulfate is absorbed3.

  4. Glucosamine sulfate, in vivo, breaks down into glucosamine and sulfate ions. Glucosamine hydrocholoride, on the other hand, breaks down into glucosamine and free hydrochloric acid. The acid would increase gastric acidity and produce the associated disturbances in vivo.

  5. The sulfate ions produced from glucosamine sulfate, on the other hand, participate in chondrometabolic processes. They influence the incorporation of glucosamine and sulfate into the tissues. In a study with gastric mucosal segments, a sulfate content of 300µ mole was found to induce maximum incorporation. Chlorate was found to inhibit glycosylation and induce the formation of low molecular weight mucin polymer. The results of this study revealed that sulfate availability is essential for the formation of high molecular weight mucin polymer. The presence of sulfate ion would therefore enhance the antiarthritic properties of glucosamine.

References:

  1. Rovalti, L.C., (1992). Antireactive properties of chondroprotective drugs. Int. J. Tissue Reactions, 14(5), 253-261.

  2. Reichelt, A. et al. (1994). Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee, a randomized, placebo-controlled double blind study. Arzneim-Forsch Drug Res. 44(l)(1), 75-80.

  3. Setnikar, 1. et al. (1993). Pharmacokinetics of glucosamine in man. Arzneim-Forsch Drug Res. 43(11)(10), 1109-1113.

  4. Liau, Y. H. et al. (1992). Role of sulfation in post-translational processing of gastric mucins. Int. J. Riochem. 24(7), 1023-1028.
 
   
  Scientific Focus : Sam P. Kumar Ph.D., Sabinsa Research Group  
 
 

Senior Director of Natural Products Chemistry, Dr. Kumar takes primary responsibility for developing new products from natural sources to address serious medical conditions.

Dr. Kumar has 23 years experience as an organic chemist. His experience includes the successful synthesis of peptides, hormones, Prostaglandins, antiinflammatorv drugs, antivirals, antihistamines and aroma chemicals.

Prior to joining Sabinsa, he was Senior Staff Chemist at Yale University, and served as Organic Biochemist for Elan Chemicals, Newark, NJ. He holds a number of patents and is widely published in professional journals.

 
   
  Sabinsa receives kosher certification  
 
 
Sabinsa recently announced that it has been authorized by the Orthodox Union to place the O.U. symbol certifying products listed under their respective brand names as kosher and pareve.

A copy of Sabinsa's kosher certified product list is available upon request.

 
   
  Sabinsa-on-wheels update : Colorado and arizone  
 
 
Sabinsa's educational training seminar will be presented at the Denver Marriott South (Englewood, Colorado) on May 14, and the following day at the Sheraton Mesa Hotel (Mesa, Arizona) on May 15.

For reservations contact Sabinsa at 908-777-1111 (8:30 a.m. - 6 p.m. EDT).

 
     
 
"The information presented in the "Current Issues" Newsletter from Sabinsa Corporation is for informational purposes only. It is abstracted from web and print media sources. Readers are advised to refer to the original sources for additional information".
 
   
Copyright © 2007 Sabinsa Corporation All Rights Reserved